Literature DB >> 19508353

Sequence-based characterization of swine leucocyte antigen alleles in commercially available porcine cell lines.

C S Ho1, M H Franzo-Romain, Y J Lee, J H Lee, D M Smith.   

Abstract

A total of 53 alleles at five highly polymorphic swine leucocyte antigen (SLA) loci (SLA-1, SLA-3, SLA-2, SLA-DRB1, and SLA-DQB1) were identified in eight commercially available porcine cell lines (ESK-4, LLC-PK1, MPK, PK13, PK15, PT-K75, SK-RST, and ST). This information is essential for the use of these cell lines to understand the role of SLA genes and proteins in swine models of transplantation, xenotransplantation, and in swine immune responses to infectious diseases and vaccines. The ready availability of these cell lines also makes them a good source of reference DNA for SLA allele typing.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19508353     DOI： 10.1111/j.1744-313X.2009.00853.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN： 1744-3121            Impact factor:   1.466


  15 in total

1.  A combined prediction strategy increases identification of peptides bound with high affinity and stability to porcine MHC class I molecules SLA-1*04:01, SLA-2*04:01, and SLA-3*04:01.

Authors:  Lasse Eggers Pedersen; Michael Rasmussen; Mikkel Harndahl; Morten Nielsen; Søren Buus; Gregers Jungersen
Journal:  Immunogenetics       Date:  2015-11-14       Impact factor: 2.846

2.  Preferred SLA class I/class II haplotype combinations in German Landrace pigs.

Authors:  Ulrike Gimsa; Chak-Sum Ho; Sabine E Hammer
Journal:  Immunogenetics       Date:  2016-08-02       Impact factor: 2.846

3.  Neo-Angiogenesis, Transplant Viability, and Molecular Analyses of Vascularized Bone Allotransplantation Surgery in a Large Animal Model.

Authors:  Rudolph H Houben; Roman Thaler; Dimitra Kotsougiani; Patricia F Friedrich; Alexander Y Shin; Andre J van Wijnen; Allen T Bishop
Journal:  J Orthop Res       Date:  2019-10-06       Impact factor: 3.494

4.  Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Authors:  Jared R Patch; Lasse E Pedersen; Felix N Toka; Mauro Moraes; Marvin J Grubman; Morten Nielsen; Gregers Jungersen; Soren Buus; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

5.  Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease.

Authors:  Luz M Reyes; Jose L Estrada; Zheng Yu Wang; Rachel J Blosser; Rashod F Smith; Richard A Sidner; Leela L Paris; Ross L Blankenship; Caitlin N Ray; Aaron C Miner; Matthew Tector; A Joseph Tector
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

6.  Molecular characterization of swine leukocyte antigen class I genes by sequence-based and PCR-SSP method in Guizhou minipigs.

Authors:  Jihan Xia; Zizhan Liu; Leilei Xin; Zaigui Wang; Lin Qian; Shuguang Wu; Shulin Yang; Kui Li
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

7.  Characterization of porcine dendritic cell response to Streptococcus suis.

Authors:  Marie-Pier Lecours; Mariela Segura; Claude Lachance; Tufaria Mussa; Charles Surprenant; Maria Montoya; Marcelo Gottschalk
Journal:  Vet Res       Date:  2011-06-02       Impact factor: 3.683

8.  Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method.

Authors:  Andres H Gutiérrez; William D Martin; Chris Bailey-Kellogg; Frances Terry; Leonard Moise; Anne S De Groot
Journal:  BMC Bioinformatics       Date:  2015-09-15       Impact factor: 3.169

9.  Specificity Characterization of SLA Class I Molecules Binding to Swine-Origin Viral Cytotoxic T Lymphocyte Epitope Peptides in Vitro.

Authors:  Caixia Gao; Xiwen He; Jinqiang Quan; Qian Jiang; Huan Lin; Hongyan Chen; Liandong Qu
Journal:  Front Microbiol       Date:  2017-12-18       Impact factor: 5.640

10.  Identification of swine influenza virus epitopes and analysis of multiple specificities expressed by cytotoxic T cell subsets.

Authors:  Lasse E Pedersen; Solvej Ø Breum; Ulla Riber; Lars E Larsen; Gregers Jungersen
Journal:  Virol J       Date:  2014-09-06       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.